Arqule Inc. buy melinda
Start price
04.05.17
/
50%
€0.90
Target price
10.05.17
€0.99
Performance (%)
-3.51%
End price
10.05.17
€0.87
Summary
This prediction ended on 10.05.17 with a price of €0.87. With a performance of -3.51%, the BUY prediction by melinda finished with a loss. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Arqule Inc. | - | - | - | - |
| iShares Core DAX® | -1,02 % | -1,14 % | 1,59 % | 50,96 % |
| iShares Nasdaq 100 | -2,52 % | -5,25 % | 26,60 % | 82,15 % |
| iShares Nikkei 225® | -4,44 % | -10,16 % | 53,01 % | 68,74 % |
| iShares S&P 500 | -1,23 % | -0,04 % | 21,56 % | 65,37 % |
Comments by melinda for this prediction
In the thread Arqule Inc. diskutieren
intrahepatischen cholangiocarcinoma
hat Einschreibung von Phase 2. Diskussion Post at ASCO am 3. abgeschlossen Juni 2017. Phase 3 für das 3. Quartal 2017 geplant.